Https:// Section 1 - Chemical Product and Company Identification MSDS Name: Caffeine
Catalog Numbers: O1728-500
Synonyms: 3,7-Dihydro-1,3,7-Trimethyl-1H-Purine-2,6-Dione; Xanthrine,1,3,7-Trimethyl; Anhydrous Caffeine;
Company Identification:
For information, call: 201-796-7100
Emergency Number: 201-796-7100
For CHEMTREC assistance, call: 800-424-9300
For International CHEMTREC assistance, call: 703-527-3887
Section 2 - Composition, Information on Ingredients Chemical Name
Warning! Harmful if swallowed. May cause eye, skin, and respiratory tract irritation. May cause digestive tract
irritation with nausea, vomiting, and diarrhea. May cause cardiac disturbances. May cause central nervous system Target Organs: Heart, central nervous system.

Potential Health Effects
Eye: Dust may cause mechanical irritation.
Skin: May cause skin irritation.
Ingestion: Harmful if swallowed. May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Ingestion
increases the metabolic rate causing warm, flushed and moist skin, muscular weakness, rapid heart rate, insomnia, nervousness, increased metabolism and weight loss. May cause ataxia, blood pressure elevation, convulsions, hallucinations, hypermotility, muscle contraction or spasticity, somnolence (general depressed activity), toxic Inhalation: May cause respiratory tract irritation. May cause effects similar to those described for ingestion.
Chronic: May cause digestive tract and cardiac disturbances. May cause reproductive and fetal effects.

Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get
Skin: Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get
medical aid if irritation develops or persists. Wash clothing before reuse. Ingestion: Call a poison control center. If swallowed, do not induce vomiting unless directed to do so by medical (1 of 5)1/26/2009 9:11:06 AM personnel. Never give anything by mouth to an unconscious person. Get medical aid. Inhalation: Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Get medical aid. Notes to Physician: Treat symptomatically and supportively.

General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH
(approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated Extinguishing Media: In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use agent
Flash Point: Not applicable.
Autoignition Temperature: 540 deg C ( 1,004.00 deg F)
Explosion Limits, Lower:Not available.
Upper: Not available.
NFPA Rating: (estimated) Health: 2; Flammability: 0; Instability: 0

General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks: Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up,
then place into a suitable container for disposal. Avoid generating dusty conditions. Provide ventilation.
Handling: Provide ventilation. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid
contact with skin and eyes. Do not ingest or inhale. Wash clothing before reuse. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible
Section 8 - Exposure Controls, Personal Protection
Engineering Controls: Use process enclosure, local exhaust ventilation, or other engineering controls to control
airborne levels below recommended exposure limits. Exposure Limits
Chemical Name
OSHA - Final PELs

OSHA Vacated PELs: CAFFEINE: No OSHA Vacated PELs are listed for this chemical.
Personal Protective Equipment
Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure.
Clothing: Wear appropriate protective clothing to minimize contact with skin.
Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or Section 9 - Physical and Chemical Properties (2 of 5)1/26/2009 9:11:06 AM
Physical State: Solid
Appearance: white
Odor: odorless
pH: Not available.
Vapor Pressure: Negligible.
Vapor Density: Not available.
Evaporation Rate:Negligible.
Viscosity: Not available.
Boiling Point: 177.8 deg C
Freezing/Melting Point:237.8 deg C
Decomposition Temperature:Not available.
Solubility: Slightly soluble in water.
Specific Gravity/Density:1.23
Molecular Formula:C8H10N4O2
Molecular Weight:194.0956

Chemical Stability: Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid: Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials: Strong oxidizing agents.
Hazardous Decomposition Products: Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases,
Hazardous Polymerization: Has not been reported.
CAS# 58-08-2: EV6475000

CAS# 58-08-2: Not listed by ACGIH, IARC, NTP, or CA Prop 65.
Epidemiology: Experimental reproductive effects have been reported.
Teratogenicity: A human teratogen, causes developmental abnormalities of the craniofacial and musculoskeletal
systems, pregnancy termination and stillbirth. Reproductive Effects: See above.
Mutagenicity: No information available.
Neurotoxicity: No information available.
Other Studies:

Ecotoxicity: No data available. No information available.
Environmental: TERRESTRIAL FATE: If released to soil, estimated soil adsorption indicate that caffeine will display
very high mobility. An estimated Henry's Law constant of 1.9X10-19 atm-cu m/mole at 25 deg C indicates that it will not volatilize from moist soil to the atmosphere. AQUATIC FATE: If released to water caffiene will not bioconcentrate (3 of 5)1/26/2009 9:11:06 AM aquatic organisms. ATMOSPHERIC FATE: Exists predominantly in the particulate phase, half life 2.5 hours. Expected Physical: No information available.
Other: No information available.
Chemical waste generators must determine whether a discarded chemical is classified as a hazardous waste. US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3. Additionally, waste generators must consult state and local hazardous waste regulations to ensure complete and accurate classification. RCRA P-Series: None listed.
RCRA U-Series: None listed.
Canada TDG
Shipping Name:
Hazard Class:
UN Number:
Packing Group:

CAS# 58-08-2 is listed on the TSCA inventory. Health & Safety Reporting List
None of the chemicals are on the Health & Safety Reporting List. Chemical Test Rules
None of the chemicals in this product are under a Chemical Test Rule. Section 12b
None of the chemicals are listed under TSCA Section 12b. TSCA Significant New Use Rule
None of the chemicals in this material have a SNUR under TSCA. CERCLA Hazardous Substances and corresponding RQs
None of the chemicals in this material have an RQ. SARA Section 302 Extremely Hazardous Substances
None of the chemicals in this product have a TPQ. SARA Codes
Section 313 No chemicals are reportable under Section 313.
Clean Air Act:
This material does not contain any hazardous air pollutants. This material does not contain any Class 1 Ozone depletors. This material does not contain any Class 2 Ozone depletors. Clean Water Act:
None of the chemicals in this product are listed as Hazardous Substances under the CWA. None of the chemicals in this product are listed as Priority Pollutants under the CWA. None of the chemicals in this product are listed as Toxic Pollutants under the CWA. None of the chemicals in this product are considered highly hazardous by OSHA. CAS# 58-08-2 is not present on state lists from CA, PA, MN, MA, FL, or NJ.
California Prop 65 (4 of 5)1/26/2009 9:11:06 AM California No Significant Risk Level: None of the chemicals in this product are listed.
European/International Regulations

European Labeling in Accordance with EC Directives
Hazard Symbols:
Risk Phrases:

Safety Phrases:

WGK (Water Danger/Protection)

Canada - DSL/NDSL
CAS# 58-08-2 is listed on Canada's DSL List. Canada - WHMIS
This product has a WHMIS classification of D1B, D2B. This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all of the information required by those regulations. Canadian Ingredient Disclosure List

MSDS Creation Date: 2/16/1999
Revision #7 Date: 2/13/2008
The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no event shall Fisher be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if Fisher has been advised of the possibility of such damages. (5 of 5)1/26/2009 9:11:06 AM


Prostaat snel diagnostiek-polikliniek (psd-poli)

Prostaat Snel Diagnostiek-polikliniek (PSD-poli) Inleiding Uw huisarts heeft voor u een afspraak gemaakt voor het spreekuur Prostaat Sneldiagnostiek voor specialistisch onderzoek, in verband met een eventuele afwijking van uw prostaat. In deze folder leest u alles over de voorbereiding op en de gang van zaken tijdens het bezoek aan deze speciale polikliniek van Tergooiziekenhuizen, loca

Tca final tpl host annoucement 7.26.13[1]

PIVOT, NEW TV NETWORK TARGETING MILLENNIALS, TAPS JACOB SOBOROFF AND CARA SANTA MARIA AS FIRST CO-HOSTS OF LIVE, LATE-NIGHT SHOW, ‘TAKEPART LIVE’ Award-Winning Producer Jim Downs Named Showrunner and Executive Producer of New Topical, Interactive Series Premiering August 1st at Midnight ET/11:00 PM CT Los Angeles, July 26, 2013 – During a presentation today for television c

Copyright © 2008-2018 All About Drugs